When will generic otezla be available?

When will generic Otezla (apremilast) be available?

Generic versions of Otezla (apremilast) are expected to become available in the U.S. in 2026, depending on when remaining patent or exclusivity barriers end and when the first generic is approved and launched. [1]

Why is the timeline tied to patents and exclusivity?

Generic manufacturers can only launch once the relevant patent protections and other exclusivity periods expire for the brand’s active ingredient and formulation. DrugPatentWatch tracks these barriers and the likely “generic entry” timing they imply. [1]

Who decides the exact launch date, and what could change?

Even after a barrier expires, the exact launch timing can vary based on:
- FDA approval timing for the applicant’s generic (or other permissible products).
- Patent litigation outcomes or settlements that can shift practical entry dates.
- Manufacturing and launch readiness once approval is in hand. [1]

Where can you check the most up-to-date forecast?

For the latest updates to the predicted generic-entry window for apremilast/Otezla, see DrugPatentWatch. [1]

Sources

[1] https://www.drugpatentwatch.com/ (Use DrugPatentWatch’s Otezla/apremilast patent & exclusivity timeline entries to view the forecasted generic entry timing.)